SCHEDULE 13G/A

KALARIS THERAPEUTICS INC

Common Stock, $0.0001 par value per share · CUSIP: 482929106

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Invus Public Equities, L.P.

  Shares: 282,586.00 · Class: 1.5%

• Invus Public Equities Advisors, LLC

  Shares: 282,586.00 · Class: 1.5%

• Invus Global Management, LLC

  Shares: 282,586.00 · Class: 1.5%

• Siren, L.L.C.

  Shares: 282,586.00 · Class: 1.5%

• Raymond Debbane

  Shares: 282,586.00 · Class: 1.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.